Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-15
DOI
10.1007/s00508-020-01735-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Novel Pharmacotherapy Options for NASH
- (2016) Vlad Ratziu DIGESTIVE DISEASES AND SCIENCES
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Arrhythmias Seen in Baseline 24-Hour Holter ECG Recordings in Healthy Normal Volunteers During Phase 1 Clinical Trials
- (2016) Pooja Hingorani et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Immunology in the liver — from homeostasis to disease
- (2016) Felix Heymann et al. Nature Reviews Gastroenterology & Hepatology
- The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)
- (2016) Marina Nati et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
- (2016) Claudia Fuchs et al. SEMINARS IN LIVER DISEASE
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Reference ranges of serum bile acids in children and adolescents
- (2015) Jörg Jahnel et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension
- (2015) Rajeshwar P. Mookerjee et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
- (2015) Jerome Boursier et al. PLoS Pathogens
- Application of localized 31P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease
- (2014) Ladislav Valkovič et al. EUROPEAN RADIOLOGY
- The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
- (2014) Maryann Maximos et al. HEPATOLOGY
- Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease
- (2014) Kentaro Yoshioka et al. HEPATOLOGY RESEARCH
- In vivo31P magnetic resonance spectroscopy of the human liver at 7 T: an initial experience
- (2014) Marek Chmelik et al. NMR IN BIOMEDICINE
- Nonalcoholic fatty liver disease: a frequent condition in type 2 diabetic patients
- (2014) Alexandra Sima et al. WIENER KLINISCHE WOCHENSCHRIFT
- Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
- (2014) Stefano Ballestri WORLD JOURNAL OF GASTROENTEROLOGY
- Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
- (2013) Abigale Lade et al. CURRENT OPINION IN ONCOLOGY
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease: Spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study
- (2013) Jill M. Abrigo et al. JOURNAL OF HEPATOLOGY
- Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
- (2013) Vincent Wai-Sun Wong et al. PLoS One
- Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: A meta-analysis of prospective cohort studies
- (2013) Guangli Du et al. PREVENTIVE MEDICINE
- Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
- (2013) Fei Li et al. Nature Communications
- Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics
- (2012) Evaggelia Liaskou et al. HEPATOLOGY
- Bile acid transporters and regulatory nuclear receptors in the liver and beyond
- (2012) Emina Halilbasic et al. JOURNAL OF HEPATOLOGY
- Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?
- (2011) Florian Hucke et al. WIENER KLINISCHE WOCHENSCHRIFT
- Colonization-Induced Host-Gut Microbial Metabolic Interaction
- (2011) S. P. Claus et al. mBio
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
- (2010) Magali Sasso et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
- (2009) Tatjana Stojakovic et al. ATHEROSCLEROSIS
- Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease
- (2009) T. Asanuma et al. GUT
- Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
- (2009) Yanqiao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Bile Acid Sensor Farnesoid X Receptor Is a Modulator of Liver Immunity in a Rodent Model of Acute Hepatitis
- (2009) A. Mencarelli et al. JOURNAL OF IMMUNOLOGY
- Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of31P metabolites in human liver
- (2008) M. Chmelík et al. MAGNETIC RESONANCE IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now